CorMedix Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

CorMedix Inc. reported Cash And Cash Equivalents At Carrying Value of $144.84 million for the year ending 2025.

  • CorMedix Inc. showed an increase of +256.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from CorMedix Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2006 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2011: $6.56 million | Q2 2011: $4.74 million | Q3 2011: $2.89 million | Q1 2012: $1.86 million | Q2 2012: $893.9 thousand | Q3 2012: $992.3 thousand | Q1 2013: $692.7 thousand | Q2 2013: $158.4 thousand | Q3 2013: $483.1 thousand | Q1 2014: $9.19 million | Q2 2014: $7.65 million | Q3 2014: $5.92 million | Q1 2015: $8.80 million | Q2 2015: $24.11 million | Q3 2015: $14.25 million | Q1 2016: $13.18 million | Q2 2016: $12.02 million | Q3 2016: $9.83 million | Q1 2017: $6.82 million | Q2 2017: $7.94 million | Q3 2017: $5.21 million | Q4 2017: $10.38 million | Q1 2018: $8.16 million | Q2 2018: $4.70 million | Q3 2018: $6.44 million | Q1 2019: $18.26 million | Q2 2019: $14.56 million | Q3 2019: $20.15 million | Q1 2020: $12.20 million | Q2 2020: $16.49 million | Q3 2020: $34.36 million | Q1 2021: $76.21 million | Q2 2021: $73.09 million | Q3 2021: $66.32 million | Q1 2022: $45.39 million | Q2 2022: $48.93 million | Q3 2022: $43.25 million | Q1 2023: $25.27 million | Q2 2023: $19.70 million | Q3 2023: $53.31 million | Q1 2024: $35.18 million | Q2 2024: $28.54 million | Q3 2024: $35.29 million | Q1 2025: $66.29 million | Q2 2025: $159.31 million | Q3 2025: $48.49 million.
  • Historical annual values: Fiscal year 2025: $144.84 million | Fiscal year 2024: $40.65 million | Fiscal year 2023: $43.64 million | Fiscal year 2022: $43.15 million | Fiscal year 2021: $53.32 million | Fiscal year 2020: $41.91 million | Fiscal year 2019: $16.35 million | Fiscal year 2018: $17.62 million | Fiscal year 2017: $10.38 million | Fiscal year 2016: $8.06 million | Fiscal year 2015: $11.82 million | Fiscal year 2014: $4.34 million | Fiscal year 2013: $2.37 million | Fiscal year 2012: $835.5 thousand | Fiscal year 2011: $1.99 million | Fiscal year 2010: $8.28 million | Fiscal year 2009: $1.51 million | Fiscal year 2006: $0.00.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: